Cell Therapy Quality/ CMC & Analytics

CELL AND GENE THERAPY INSIGHTS

January 2019

Cell Therapy Quality/ CMC & Analytics

Download PDF

Expert Insight

Standards Landscape in Cell Counting: Implications for Cell & Gene Therapy

Standards Landscape in Cell Counting: Implications for Cell & Gene Therapy

S Sarkar, L Pierce, S Lin-Gibson et al.

15 February 2019

Using Machine Learning for Critical Quality Attribute Discovery in Cell Therapy Manufacture

Using Machine Learning for Critical Quality Attribute Discovery in Cell Therapy Manufacture

Dan Charles Wilkinson, Stefan Irion

14 February 2019

How to Reduce the Vein to Vein Timeframe Through Efficient, Accelerated QC & Release Testing

How to Reduce the Vein to Vein Timeframe Through Efficient, Accelerated QC & Release Testing

14 February 2019

Perspective

An Academic Model for Cell & Gene Therapy Asset Development

An Academic Model for Cell & Gene Therapy Asset Development

14 February 2019

Interview

Critical considerations & common mistakes in early-phase CMC development

Critical considerations & common mistakes in early-phase CMC development

18 February 2019

European regulator’s perspective: best practice & future directions in cell therapy CMC

European regulator’s perspective: best practice & future directions in cell therapy CMC

Margarida Menezes Ferreira

15 February 2019

Next steps in MSC cell therapy characterization

Next steps in MSC cell therapy characterization

15 February 2019

Optimizing quality & compliance for cord blood-derived cells

Optimizing quality & compliance for cord blood-derived cells

Roger Horton, Chris Leonforte

15 February 2019